These findings offer novel insights into evaluating the biological behavior of prostate cancer tumors using 68Ga-PSMA-11 PET/MR imaging, albeit further validation and exploration are warranted to fully elucidate their clinical utility. This evidence concerns the gene FOLH1 and prostate carcinoma.